Ashlee D. Brunaugh

632 total citations
16 papers, 420 citations indexed

About

Ashlee D. Brunaugh is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Infectious Diseases. According to data from OpenAlex, Ashlee D. Brunaugh has authored 16 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 5 papers in Pharmaceutical Science and 4 papers in Infectious Diseases. Recurrent topics in Ashlee D. Brunaugh's work include Inhalation and Respiratory Drug Delivery (11 papers), Drug Solubulity and Delivery Systems (4 papers) and Microencapsulation and Drying Processes (4 papers). Ashlee D. Brunaugh is often cited by papers focused on Inhalation and Respiratory Drug Delivery (11 papers), Drug Solubulity and Delivery Systems (4 papers) and Microencapsulation and Drying Processes (4 papers). Ashlee D. Brunaugh collaborates with scholars based in United States, Chile and Austria. Ashlee D. Brunaugh's co-authors include Hugh D. C. Smyth, Silvia Ferrati, Tian Wu, Li Ding, Kristin Fathe, Jason T. McConville, Mark R. Prausnitz, Javier Morales, Song Li and Syed Umer Jan and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and International Journal of Pharmaceutics.

In The Last Decade

Ashlee D. Brunaugh

15 papers receiving 408 citations

Peers

Countries citing papers authored by Ashlee D. Brunaugh

Since Specialization

Citations

This map shows the geographic impact of Ashlee D. Brunaugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashlee D. Brunaugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashlee D. Brunaugh more than expected).

Fields of papers citing papers by Ashlee D. Brunaugh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashlee D. Brunaugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashlee D. Brunaugh. The network helps show where Ashlee D. Brunaugh may publish in the future.

Co-authorship network of co-authors of Ashlee D. Brunaugh

This figure shows the co-authorship network connecting the top 25 collaborators of Ashlee D. Brunaugh. A scholar is included among the top collaborators of Ashlee D. Brunaugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashlee D. Brunaugh. Ashlee D. Brunaugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Physiologically informed in vitro framework reveals context-dependent combinatory activity of niclosamide–colistin against Gram-negative bacteria 2025 ·Journal of Antimicrobial Chemotherapy ·(unknown), M Park, (unknown), Lindsay J. Caverly, Ashlee D. Brunaugh	0
2	Essential Pharmaceutics 2024 ·Ashlee D. Brunaugh, (unknown), (unknown), Hugh D. C. Smyth, Robert O. Williams	1
3	Development of low-cost, weight-adjustable clofazimine mini-tablets for treatment of tuberculosis in pediatrics 2023 ·European Journal of Pharmaceutical Sciences ·Zachary N. Warnken, (unknown), (unknown), (unknown), John J. Koleng, Hugh D. C. Smyth, Ashlee D. Brunaugh	4
4	Respirable Clofazimine Particles Produced by Air Jet Milling Technique Are Efficacious in Treatment of BALB/c Mice with Chronic Mycobacterium tuberculosis Infection 2022 ·Antimicrobial Agents and Chemotherapy ·Ashlee D. Brunaugh, (unknown), Zachary N. Warnken, (unknown), (unknown), John J. Koleng, Hugh D. C. Smyth, Mercedes Gonzalez‐Juarrero	8
5	Identification of Stability Constraints in the Particle Engineering of an Inhaled Monoclonal Antibody Dried Powder 2021 ·Journal of Pharmaceutical Sciences ·Ashlee D. Brunaugh, Li Ding, Tian Wu, Michael Schneider, (unknown), Hugh D. C. Smyth	11
6	Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae 2021 ·PLoS ONE ·Ashlee D. Brunaugh, (unknown), Zachary N. Warnken, Li Ding, Sang Heui Seo, Hugh D. C. Smyth	50
7	Inhaled fixed-dose combination powders for the treatment of respiratory infections 2021 ·Expert Opinion on Drug Delivery ·Ashlee D. Brunaugh, (unknown), Hugh D. C. Smyth	18
8	A Quality by Design Framework for Capsule-Based Dry Powder Inhalers 2021 ·Pharmaceutics ·Li Ding, Ashlee D. Brunaugh, Sven Stegemann, Scott V. Jermain, (unknown), (unknown), Hugh D. C. Smyth	20
9	Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders 2019 ·Molecular Pharmaceutics ·Ashlee D. Brunaugh, Tian Wu, (unknown), Hugh D. C. Smyth	40
10	Essential Pharmaceutics 2019 ·Ashlee D. Brunaugh, Hugh D. C. Smyth, Robert O. Williams	12
11	Formulation techniques for high dose dry powders 2018 ·International Journal of Pharmaceutics ·Ashlee D. Brunaugh, Hugh D. C. Smyth	46
12	Influence of Formulation Factors on the Aerosol Performance and Stability of Lysozyme Powders: a Systematic Approach 2018 ·AAPS PharmSciTech ·Silvia Ferrati, Tian Wu, (unknown), Ashlee D. Brunaugh, (unknown), Hugh D. C. Smyth	22
13	Process optimization and particle engineering of micronized drug powders via milling 2017 ·Drug Delivery and Translational Research ·Ashlee D. Brunaugh, Hugh D. C. Smyth	25
14	Challenges and Future Prospects for the Delivery of Biologics: Oral Mucosal, Pulmonary, and Transdermal Routes 2017 ·The AAPS Journal ·Javier Morales, Kristin Fathe, Ashlee D. Brunaugh, Silvia Ferrati, Song Li, (unknown), (unknown), Jason T. McConville, Mark R. Prausnitz, Hugh D. C. Smyth	112
15	Excipient-Free Pulmonary Delivery and Macrophage Targeting of Clofazimine via Air Jet Micronization 2017 ·Molecular Pharmaceutics ·Ashlee D. Brunaugh, Syed Umer Jan, Silvia Ferrati, Hugh D. C. Smyth	40
16	Connexin membrane materials as potent inhibitors of breast cancer cell migration 2017 ·Journal of The Royal Society Interface ·Silvia Ferrati, Avinash K. Gadok, Ashlee D. Brunaugh, Chi Zhao, (unknown), Hugh D. C. Smyth, Jeanne C. Stachowiak	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact